13-23335023-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014363.6(SACS):​c.8853T>C​(p.Val2951Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 1,613,350 control chromosomes in the GnomAD database, including 58,049 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V2951V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.23 ( 4559 hom., cov: 33)
Exomes 𝑓: 0.27 ( 53490 hom. )

Consequence

SACS
NM_014363.6 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.156

Publications

19 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women's Health, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014363.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 13-23335023-A-G is Benign according to our data. Variant chr13-23335023-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.156 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.8853T>Cp.Val2951Val
synonymous
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.8880T>Cp.Val2960Val
synonymous
Exon 11 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.8412T>Cp.Val2804Val
synonymous
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.8853T>Cp.Val2951Val
synonymous
Exon 10 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.2432-5539T>C
intron
N/AENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.8880T>Cp.Val2960Val
synonymous
Exon 11 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34398
AN:
152080
Hom.:
4556
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0914
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.326
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.338
Gnomad SAS
AF:
0.356
Gnomad FIN
AF:
0.235
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.257
Gnomad OTH
AF:
0.256
GnomAD2 exomes
AF:
0.287
AC:
71940
AN:
250780
AF XY:
0.288
show subpopulations
Gnomad AFR exome
AF:
0.0885
Gnomad AMR exome
AF:
0.388
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.350
Gnomad FIN exome
AF:
0.246
Gnomad NFE exome
AF:
0.257
Gnomad OTH exome
AF:
0.278
GnomAD4 exome
AF:
0.266
AC:
388691
AN:
1461152
Hom.:
53490
Cov.:
40
AF XY:
0.268
AC XY:
195147
AN XY:
726852
show subpopulations
African (AFR)
AF:
0.0856
AC:
2859
AN:
33416
American (AMR)
AF:
0.378
AC:
16896
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
10481
AN:
26094
East Asian (EAS)
AF:
0.345
AC:
13702
AN:
39686
South Asian (SAS)
AF:
0.341
AC:
29430
AN:
86220
European-Finnish (FIN)
AF:
0.239
AC:
12738
AN:
53364
Middle Eastern (MID)
AF:
0.326
AC:
1879
AN:
5762
European-Non Finnish (NFE)
AF:
0.256
AC:
284949
AN:
1111574
Other (OTH)
AF:
0.261
AC:
15757
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
17277
34554
51831
69108
86385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9810
19620
29430
39240
49050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.226
AC:
34413
AN:
152198
Hom.:
4559
Cov.:
33
AF XY:
0.231
AC XY:
17215
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0915
AC:
3801
AN:
41550
American (AMR)
AF:
0.326
AC:
4985
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1392
AN:
3470
East Asian (EAS)
AF:
0.339
AC:
1753
AN:
5178
South Asian (SAS)
AF:
0.354
AC:
1710
AN:
4824
European-Finnish (FIN)
AF:
0.235
AC:
2497
AN:
10606
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.257
AC:
17489
AN:
67960
Other (OTH)
AF:
0.258
AC:
545
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1323
2646
3970
5293
6616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
8961
Bravo
AF:
0.230
Asia WGS
AF:
0.317
AC:
1103
AN:
3478
EpiCase
AF:
0.265
EpiControl
AF:
0.268

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
3
Charlevoix-Saguenay spastic ataxia (3)
-
-
3
not provided (3)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.45
DANN
Benign
0.62
PhyloP100
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs9552929;
hg19: chr13-23909162;
COSMIC: COSV104428861;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.